A detailed history of Zions Bancorporation, N.A. transactions in Astrazeneca PLC stock. As of the latest transaction made, Zions Bancorporation, N.A. holds 12,332 shares of AZN stock, worth $794,674. This represents 0.07% of its overall portfolio holdings.

Number of Shares
12,332
Previous 9,060 36.11%
Holding current value
$794,674
Previous $706,000 35.98%
% of portfolio
0.07%
Previous 0.06%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$76.67 - $87.62 $250,864 - $286,692
3,272 Added 36.11%
12,332 $960,000
Q2 2024

Aug 08, 2024

BUY
$66.81 - $80.83 $487,779 - $590,139
7,301 Added 415.07%
9,060 $706,000
Q1 2024

May 14, 2024

SELL
$61.03 - $69.57 $5,431 - $6,191
-89 Reduced 4.82%
1,759 $119,000
Q4 2023

Feb 12, 2024

SELL
$61.89 - $69.28 $1,671 - $1,870
-27 Reduced 1.44%
1,848 $124,000
Q3 2023

Nov 07, 2023

SELL
$64.85 - $71.7 $843 - $932
-13 Reduced 0.69%
1,875 $126,000
Q2 2023

Jul 28, 2023

SELL
$69.91 - $75.81 $169,951 - $184,294
-2,431 Reduced 56.29%
1,888 $135,000
Q1 2023

May 10, 2023

SELL
$63.15 - $71.6 $104,639 - $118,641
-1,657 Reduced 27.73%
4,319 $299,000
Q4 2022

Feb 10, 2023

BUY
$54.21 - $70.44 $35,344 - $45,926
652 Added 12.25%
5,976 $405,000
Q3 2022

Nov 08, 2022

BUY
$53.02 - $135.75 $166,323 - $425,847
3,137 Added 143.44%
5,324 $292,000
Q2 2022

Aug 05, 2022

BUY
$59.26 - $71.14 $2,844 - $3,414
48 Added 2.24%
2,187 $144,000
Q1 2022

May 13, 2022

BUY
$55.72 - $67.12 $6,352 - $7,651
114 Added 5.63%
2,139 $142,000
Q4 2021

Feb 11, 2022

SELL
$54.02 - $63.83 $648 - $765
-12 Reduced 0.59%
2,025 $118,000
Q3 2021

Nov 10, 2021

SELL
$55.56 - $60.79 $40,281 - $44,072
-725 Reduced 26.25%
2,037 $122,000
Q2 2021

Aug 11, 2021

BUY
$48.42 - $60.18 $9,199 - $11,434
190 Added 7.39%
2,762 $165,000
Q1 2021

May 13, 2021

SELL
$47.16 - $54.44 $255,088 - $294,465
-5,409 Reduced 67.77%
2,572 $128,000
Q4 2020

Feb 12, 2021

SELL
$48.52 - $58.02 $13,779 - $16,477
-284 Reduced 3.44%
7,981 $399,000
Q3 2020

Nov 13, 2020

BUY
$53.07 - $61.1 $31,205 - $35,926
588 Added 7.66%
8,265 $453,000
Q2 2020

Aug 13, 2020

SELL
$43.1 - $55.31 $44,910 - $57,633
-1,042 Reduced 11.95%
7,677 $406,000
Q1 2020

May 15, 2020

BUY
$37.79 - $51.33 $19,764 - $26,845
523 Added 6.38%
8,719 $389,000
Q4 2019

Feb 14, 2020

SELL
$42.46 - $50.46 $49,932 - $59,340
-1,176 Reduced 12.55%
8,196 $409,000
Q3 2019

Nov 13, 2019

BUY
$40.12 - $45.47 $376,004 - $426,144
9,372 New
9,372 $418,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $200B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Zions Bancorporation, N.A. Portfolio

Follow Zions Bancorporation, N.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zions Bancorporation, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Zions Bancorporation, N.A. with notifications on news.